Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MEN2312 |
Synonyms | |
Therapy Description |
Limited information is currently available on MEN2312, a putative KAT6A inhibitor (Oct 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MEN2312 | MEN-2312|MEN 2312 | Limited information is currently available on MEN2312, a putative KAT6A inhibitor (Oct 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06638307 | Phase I | Elacestrant + MEN2312 MEN2312 | A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer | Recruiting | USA | ITA | FRA | ESP | DEU | 1 |